EpiCARE: a European Reference Network
for rare and complex epilepsies

Course postponed to 2022

The new date for the 11th Summer School for Neuropathology and Epilepsy Surgery in Erlangen, Germany will be September 8-11, 2022.

Workshop Description

Reliable neuropathological work-up of epilepsy-associated brain lesions represents an important diagnostic value for the surgical management of patients with drug-resistant focal epilepsy. The international classification of epilepsies recognizes a large spectrum of brain lesions as potential predictors of disease progression and treatment response. The 11th International Summer School for Neuropathology and Epilepsy Surgery is designed to enable participants to better recognize and classify various histopathological substrates of drug-resistant epilepsy. Topics related to the diagnosis and treatment of human focal epilepsies will be presented by internationally renowned faculty. Advanced hands-on histopathology training will be offered in small groups led by distinguished tutors who will review and discuss microscopy slides of selected cases with different staining protocols. Participants will also have the opportunity to present their own cases for discussion with the entire group. The workshop has been held in Germany, Brazil, USA and China since 2013, with the endorsement of the International League Against Epilepsy (ILAE).

Learning Objectives

1.1.1 Demonstrate working knowledge of etiologies for focal and generalized epilepsies in children and adults (Level 1-3) with particular emphasis on hippocampal sclerosis, glio-neuronal brain tumors and malformations of cortical development (see also 1.1.2, 1.1.4 and 1.1.6)

Target Audience

Neuro-/Pathologists, Epileptologists, Neurosurgeons & Neurologists, Neuroimager and Basic Researcher

Registration

Please register in advance as room will be limited to 50 participants. No on-site registration available. All approved applications and paid registration fees for the (cancelled) 2020&2021 course will be remain valid. To be considered, applications must be received by April 1st 2022. Details here: INES 2022 Flyer

It is our greatest pleasure to invite you to the 8^th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. These meetings have been held every two years since 2007, and the series has become a landmark meeting in the international epilepsy calendar. Due to the COVID-19 pandemic we had to postpone the meeting which was planned for 2021 and are now happy to welcome you back for an in-person meeting in September 2022 in Salzburg.

We have put together an exciting programme with a Top-International Faculty. There have been major advances in the field over the past years regarding better mechanistic understanding and new treatments, as well as clinical strategies.

In addition, it is our greatest pleasure to announce the 2^nd European Course on continuous EEG in intensive care. This rapidly emerging field deserves further attention in education and implementation of this valuable diagnostic tool. The course is organised as a Pre-Colloquium Course and you can register separately for the Course only or you take the advantage of registering for both, with a discount.

We look forward to seeing and welcoming you to the 8^th London-Innsbruck Colloquium on Status Epilepticus and acute Seizures as well as the Pre-Colloquium Course on continuous EEG monitoring in ICU’s in Salzburg in September 2022!

With best regards,
Eugen Trinka, Simon Shorvon and Matthew Walker

Great news! The organizers have decided to grant every EpiCARE member a reduced rate for the colloquium. I.e. early registration rate until the congress. To benefit from this rate, you can register by sending a mail to status@cmi.at.

See the programme here

‘DEFINING THE FUTURE FOR AHC & ATP1A3 DISEASES’

————————

A 3 DAY UNIQUE EVENT INCORPORATING:

• 10-year anniversary conference commemorating the discovery of the ATP1A3 gene in AHC and ATP1A3 diseases

• The 10th Symposium on ATP1A3 in disease

This 3 Day unique event will be focused on those most impacted by research outcomes; with an opportunity to learn from their experiences and their priorities for future research to improve the research landscape and clinical care.

It will also include an overview of the last 10 years since the gene discovery, alongside current and future research plans for AHC and ATP1A3 Diseases.

—————————–

Where? – Hybrid event – EDINBURGH and ONLINE

Face-toFace VENUE:

Conference Centre, The Royal College of Physicians of Edinburgh,

9 Queens Street, Edinburgh, EH2 1JQ

When? – 19th-21st October 2022

The conference will run from Wednesday-Friday (programme to be released shortly), with an evening formal dinner for delegates and speakers on Thursday 20th October (Great Hall, The Royal College of Physicians of Edinburgh)

——————–

BRINGING TOGETHER PEOPLE WITH LIVED EXPERIENCE OF

AHC AND ATP1A3 DISEASES, RESEARCHERS AND CLINICIANS

——————-

To submit an oral or poster presentation, please email: support@ahcuk.org by 31st August 2022. All submissions must use accessible language and style. Prizes for best oral and poster presentation.

——————–

The co-applicants and organising committee of the 10-year conference and 10th Symposium on ATP1A3 in disease are grateful for the generous grant from the European Joint Programme on Rare Diseases to support this event.